CAR-T therapy: incredible data for 3 patients with brain tumors
First success of CAR-T therapy on solid brain tumors: drastic regression of glioblastoma in 3 patients. The path is the right one.
First success of CAR-T therapy on solid brain tumors: drastic regression of glioblastoma in 3 patients. The path is the right one.
This is how scientific research is transforming Escherichia Coli into a precious ally in the fight against all tumors
ERX-41 shows such promising results that it immediately leads to clinical trials - hope is now a versatile cure for several difficult cancers.
These “factories” capable of continuously delivering the drug in a targeted manner were injected into mice and cured colorectal and ovarian tumors in just under a week.
A team achieves a notable "upgrade" of CAR-T cells, making them effective even with solid and deep tumors.
A "lowest common denominator" of all tumors has just been discovered: it can change the fate of many therapies.
A Cardiff team accidentally discovers a new type of T cell, equipped with a receptor that could lead to universal cure for all types of cancer.
Detect tumors in two hours, with a single drop of blood and over 99% accuracy? Toshiba has developed a revolutionary method.
The device is able to "smell" the surgical smoke produced by the cuts of the electric scalpel, distinguishing the type of tumor and tissue (and helping the neurosurgeon in real time)
This is the case of "nanobots" or microscopic machines (about 50 nanometers in size) that science fiction had imagined in the Star Trek series and which, injected into a patient's circulation, went there to rebuild damaged tissues, eliminate pathogens such as viruses and resistant bacteria or even eradicate a cancer. Unfortunately, the economic factor often stops the ideas and drive towards innovation of motivated researchers: no one puts in the money and the research remains on paper. … Read more
AI accelerates the pace of biotech innovation: are we ready to do what is necessary to drive this epochal transformation?
Shocking research: metropolises are growing like tumors. Same principle of vascularization. We need a new approach to urban planning, starting from medicine.
Decaffeinated alarm in the States: often treated with chloroform, a carcinogen. Petitions for a stop, but the problem is the entire food system.
For Andrew Scott it's time for a second longevity revolution: not just longer lives, but healthier ones. We need to rethink healthcare, work, pensions and cultural norms.
In the new implantable Na-O2 battery, tissue oxygen acts as fuel. It can power devices, and even be therapeutic.
A new Australian study reveals the potential of the Ku70 protein to put bowel cancer cells dormant.
Joe Betts-LaCroix and Retro Biosciences open the doors of their secret laboratory: an ambitious longevity project financed with 180 million dollars.
In clinical trials, divarasib was effective in slowing the development of tumors in colorectal cancer, with manageable side effects and high tolerability.
The quick and inexpensive blood test detects a protein produced by tumor cells even before symptoms begin.
The GCN5 enzyme is crucial: if it functions poorly it can cause cancer and diabetes. That's why it can become the centerpiece of important new drugs.
A new AI-powered tool promises to revolutionize the way doctors estimate the survival of cancer patients.